Related Experiment Video
Updated: Jun 19, 2026
06:35
Alternative Methods for the Detection of Superoxide Anion Generation in Platelets
Published on: March 29, 2024
HO-1 and CO decrease platelet-derived growth factor-induced vascular smooth muscle cell migration via inhibition of
Andres I Rodriguez1, Archana Gangopadhyay, Eric E Kelley
1Department of Surgery, University of Pittsburgh School of Medicine, 3501 5 Ave, BST3 Room 6058, Pittsburgh, PA 15261, USA.
Arteriosclerosis, Thrombosis, and Vascular Biology
|October 31, 2009
Summary
Heme oxygenase-1 (HO-1) and carbon monoxide (CO) inhibit vascular smooth muscle cell migration by blocking Nox1 activity. This finding reveals a new mechanism for HO-1
Area of Science:
- Cardiovascular Biology
- Cellular Signaling
- Vascular Biology
Background:
- Heme oxygenase-1 (HO-1) and its products offer protection in vascular injury models.
- Vascular smooth muscle cell (VSMC) migration is key to neointima formation.
- The impact of HO-1 on VSMC migration remains unstudied.
Purpose of the Study:
- To investigate the effect of increased HO-1 expression on VSMC migration.
- To determine the role of HO-1 degradation products (biliverdin, bilirubin, carbon monoxide) in VSMC migration.
- To elucidate the underlying molecular mechanisms, specifically the involvement of Nox1.
Main Methods:
- In vitro models of VSMC migration were utilized.
- HO-1 expression and CO levels were modulated.
- Nox1 activity was assessed using superoxide detection, NADPH oxidase assays, and siRNA.
- Platelet-derived growth factor-stimulated signaling pathways were analyzed.
Main Results:
- Increased HO-1 expression and CO significantly inhibited VSMC migration.
- Biliverdin and bilirubin did not affect VSMC migration.
- Inhibition of VSMC migration by HO-1 and CO was mediated by Nox1.
- CO reduced platelet-derived growth factor-stimulated, redox-sensitive signaling.
Conclusions:
- Increased HO-1 expression and CO inhibit VSMC migration by suppressing Nox1 activity.
- This study identifies a novel mechanism for the protective effects of HO-1 and CO in arterial inflammation and injury.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:21Paracrine Signaling
Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...